+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bone Morphogenetic Protein Market by Type, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011048
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bone Morphogenetic Protein Market grew from USD 1.63 billion in 2023 to USD 1.88 billion in 2024. It is expected to continue growing at a CAGR of 14.81%, reaching USD 4.31 billion by 2030.

Bone Morphogenetic Proteins (BMPs) are a group of growth factors belonging to the transforming growth factor beta (TGF-β) superfamily. Initially identified for their ability to induce bone formation, BMPs play a crucial role in the development, repair, and regeneration of bone and cartilage. They find applications in orthopedics to enhance bone healing in fractures, non-unions, and spinal fusions, and are also explored in dentistry for periodontal regeneration. The BMP market is primarily influenced by the rising prevalence of orthopedic conditions, growing geriatric population, and increasing incidences of sports injuries and accidents. Moreover, advancements in biotechnology and increasing R&D investments are expected to unlock new therapeutic avenues for BMPs, such as in cardiovascular repair and wound healing. Nonetheless, the market also faces limitations such as high treatment costs, potential side effects, and stringent regulatory norms restricting their widespread adoption. Penetrating emerging markets could face hurdles due to affordability issues and lack of awareness. To capitalize on growth opportunities, businesses can focus on developing cost-effective BMP products, expanding indications for their use, and enhancing delivery and formulation technologies. Additionally, collaborations and partnerships between biotech firms and research institutions can accelerate innovation and market penetration. With personalized medicine evolving, investment in understanding patient-specific responses to BMPs may optimize therapeutic outcomes. The innovation landscape presents potential in novel delivery mechanisms, like nanoparticles or hydrogels, to increase BMP stability and efficacy. The competitive nature requires continuous innovation and emphasis on safety and efficacy in clinical trials. Businesses should also focus on educating healthcare professionals on BMP utility and safety to bolster adoption rates. Overall, the BMP market offers a promising opportunity footprint, provided companies strategically navigate through existing and emerging challenges.

Understanding Market Dynamics in the Bone Morphogenetic Protein Market

The Bone Morphogenetic Protein Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence rate of sports-related injuries and spinal fusion procedure
    • Increasing awareness regarding the bone morphogenetic protein
    • Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects
  • Market Restraints
    • High cost of the procedure
  • Market Opportunities
    • Growing demand for minimally invasive medical procedures
    • Developing advancements in treatment lines for traumatic injuries
  • Market Challenges
    • Availability of the substitute treatment and products such as bone grafts and scaffolds

Exploring Porter’s Five Forces for the Bone Morphogenetic Protein Market

Porter’s Five Forces framework further strengthens the insights of the Bone Morphogenetic Protein Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Bone Morphogenetic Protein Market

External macro-environmental factors deeply influence the performance of the Bone Morphogenetic Protein Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Bone Morphogenetic Protein Market

The Bone Morphogenetic Protein Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bone Morphogenetic Protein Market

The Bone Morphogenetic Protein Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Bone Morphogenetic Protein Market

The Bone Morphogenetic Protein Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Morphogenetic Protein Market, highlighting leading vendors and their innovative profiles. These include Akron Biotechnology, LLC, AlloSource, Inc., Bioventus LLC, Cellumed Co. Ltd, Ember Therapeutics Inc., Hangzhou Jiuyuan Gene Engineering Co .,Ltd, HiMedia Laboratories, Integra Lifesciences Corporation, Johnson & Johnson Services Inc., Medtronic PLC, Merck KGaA, Olympus Corporation, Orthofix Holdings, Inc., Pfizer, Inc., Prospec-Tany Technogene Ltd., R&D Systems, Inc., ScienCell Research Laboratories, Inc., Sino Biological Inc., Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific, Inc, Xtant Medical Holdings, Inc, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Bone Morphogenetic Protein Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • rhBMP-2
    • rhBMP-7
  • Application
    • Oral Maxillofacial
    • Reconstruction
    • Spinal fusion
    • Trauma
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence rate of sports-related injuries and spinal fusion procedure
5.1.1.2. Increasing awareness regarding the bone morphogenetic protein
5.1.1.3. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects
5.1.2. Restraints
5.1.2.1. High cost of the procedure
5.1.3. Opportunities
5.1.3.1. Growing demand for minimally invasive medical procedures
5.1.3.2. Developing advancements in treatment lines for traumatic injuries
5.1.4. Challenges
5.1.4.1. Availability of the substitute treatment and products such as bone grafts and scaffolds
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Bone Morphogenetic Protein Market, by Type
6.1. Introduction
6.2. rhBMP-2
6.3. rhBMP-7
7. Bone Morphogenetic Protein Market, by Application
7.1. Introduction
7.2. Oral Maxillofacial
7.3. Reconstruction
7.4. Spinal fusion
7.5. Trauma
8. Americas Bone Morphogenetic Protein Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Bone Morphogenetic Protein Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Bone Morphogenetic Protein Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BONE MORPHOGENETIC PROTEIN MARKET RESEARCH PROCESS
FIGURE 2. BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BONE MORPHOGENETIC PROTEIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BONE MORPHOGENETIC PROTEIN MARKET DYNAMICS
TABLE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-2, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-7, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ORAL MAXILLOFACIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TRAUMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Bone Morphogenetic Protein market, which are profiled in this report, include:
  • Akron Biotechnology, LLC
  • AlloSource, Inc.
  • Bioventus LLC
  • Cellumed Co. Ltd
  • Ember Therapeutics Inc.
  • Hangzhou Jiuyuan Gene Engineering Co .,Ltd
  • HiMedia Laboratories
  • Integra Lifesciences Corporation
  • Johnson & Johnson Services Inc.
  • Medtronic PLC
  • Merck KGaA
  • Olympus Corporation
  • Orthofix Holdings, Inc.
  • Pfizer, Inc.
  • Prospec-Tany Technogene Ltd.
  • R&D Systems, Inc.
  • ScienCell Research Laboratories, Inc.
  • Sino Biological Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Thermo Fisher Scientific, Inc
  • Xtant Medical Holdings, Inc
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information